Vivani Medical Inc (VANI) Stock Price, Quote & News

Company Profile

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients...

Industry: Biotechnology

Sector: Healthcare

Phone: 415 506 8462

Website: www.vivani.com

Address:

1350 South Loop Road, Alameda, United States

BiotechSheff Aug. 19 at 2:33 PM

$VANI … $1.50 I think Novo-Nordisk thinks they nail this study in Nov when data released that’s why the partnership!

0 · Reply

TradeMark79 Aug. 19 at 2:10 PM

$VANI added this morning…GLTA!

0 · Reply

Kkai14 Aug. 19 at 11:08 AM

$VANI needs a move like CLRO 🤞

0 · Reply

shahidattar Aug. 19 at 2:03 AM

$VANI seems like it's going cuckooo

0 · Reply

TradeMark79 Aug. 18 at 8:13 PM

$VANI watching 🤙🏼

0 · Reply

GreeneggsandJam Aug. 18 at 8:06 PM

$VANI I established a position end of march. Finally some movement

0 · Reply

martyn78 Aug. 15 at 2:05 PM

$VANI this one keeps giving me reasons to look again

0 · Reply

focafoca99 Aug. 13 at 8:55 PM

$VANI emphasized its Q2 2026 financial results and business update in a press release attached to the 8-K. https://www.rapidticker.com/news/vani-sec-filing-ba1c76

0 · Reply

Kkai14 Aug. 12 at 9:41 AM

$VANI waiting......🤞

1 · Reply

ebk81 Aug. 11 at 8:19 AM

$CLRO if you guy's really want to invest in them the safer way and avoid all this is dilution is to buy the other company $VANI witch will retain 84% of value when they merge as oppose to 16% for ClearOne stockholders. better be patient and simply wait until the merger is completed and buy when new ticker CRGT Cortigent Holdings starts trading i will also wait a few days until price settles.

0 · Reply

Vivani Medical Slides: Investor presentation

Aug 13, 2026, 4:05 PM EDT - 5 days ago

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

Aug 13, 2026, 7:00 AM EDT - 6 days ago

Vivani Medical Quarterly report: Q2 2026

Aug 13, 2026, 7:00 AM EDT - 6 days ago

Vivani Medical Earnings release: Q2 2026

2026-08-06T14:01:01.000Z - 13 days ago

Vivani Medical announces full enrollment, initial dosing in SLIM-1 trial

Aug 6, 2026, 8:00 AM EDT - 13 days ago

Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Jul 15, 2026, 4:10 PM EDT - 4 weeks ago

Vivani Medical Transcript: Emerging Growth Conference

Jul 14, 2026, 4:03 PM EDT - 5 weeks ago

Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026

Jul 11, 2026, 8:00 AM EDT - 5 weeks ago

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

2026-07-07T11:46:09.000Z - 6 weeks ago

Vivani Medical enters pact with Novo Nordisk to evaluate NPM-139

NVO

Jul 7, 2026, 7:35 AM EDT - 6 weeks ago

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Jul 6, 2026, 7:00 AM EDT - 6 weeks ago

Vivani Medical Slides: Corporate presentation

2026-07-02T12:20:21.000Z - 6 weeks ago

Vivani Medical to merge Cortigent subsidiary with ClearOne

CLRO

2026-07-02T12:05:14.000Z - 6 weeks ago

ClearOne enters into merger agreement with Cortigent

CLRO

Jul 2, 2026, 8:00 AM EDT - 6 weeks ago

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Jul 2, 2026, 8:00 AM EDT - 6 weeks ago

ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical

CLRO

Jun 26, 2026, 7:30 AM EDT - 7 weeks ago

Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker

2026-06-25T11:45:15.000Z - 7 weeks ago

Vivani receives approval from Bellberry to initiate SLIM-1 trial in Australia

Jun 25, 2026, 7:30 AM EDT - 7 weeks ago

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

2026-06-23T12:36:47.000Z - 2 months ago

Vivani Medical initiated with a Buy at Lake Street

Jun 22, 2026, 4:03 PM EDT - 2 months ago

Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention

2026-06-16T13:25:16.000Z - 2 months ago

Vivani Medical director buys $2.0M in common stock

Jun 4, 2026, 11:05 AM EDT - 2 months ago

Vivani Medical Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 11:05 AM EDT - 2 months ago

Vivani Medical Slides: FY 2026

Jun 4, 2026, 7:00 AM EDT - 2 months ago

Vivani Medical Slides: Corporate presentation

May 13, 2026, 4:05 PM EDT - 3 months ago

Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update

May 13, 2026, 7:00 AM EDT - 3 months ago

Vivani Medical Quarterly report: Q1 2026

May 13, 2026, 7:00 AM EDT - 3 months ago

Vivani Medical Earnings release: Q1 2026

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Vivani Medical Proxy statement: Proxy filing

2026-03-31T15:51:53.000Z - 5 months ago

Vivani Medical price target lowered to $3.50 from $4 at H.C. Wainwright

Mar 26, 2026, 4:16 PM EDT - 5 months ago

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Mar 26, 2026, 7:00 AM EDT - 5 months ago

Vivani Medical Earnings release: Q4 2025

Mar 26, 2026, 7:00 AM EDT - 5 months ago

Vivani Medical Annual report: Q4 2025

2026-01-29T12:41:03.000Z - 7 months ago

Vivani’s Cortigent presents 6-year results for Orion system at NANS 2026

Jan 29, 2026, 7:30 AM EST - 7 months ago

Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026

Jan 27, 2026, 4:05 PM EST - 7 months ago

Vivani Medical, Inc. Announces Closing of Common Stock Offering

Jan 25, 2026, 11:36 PM EST - 7 months ago

Vivani Medical, Inc. Announces Pricing of Common Stock Offering

2026-01-22T12:18:05.000Z - 7 months ago

Vivani subsidiary to present poster on Orion Visual Cortical Prosthesis System

Jan 9, 2026, 6:00 AM EST - 7 months ago

Vivani Medical Slides: Corporate presentation

Nov 13, 2025, 8:00 AM EST - 9 months ago

Vivani Medical Quarterly report: Q3 2025

Nov 13, 2025, 8:00 AM EST - 9 months ago

Vivani Medical Earnings release: Q3 2025

2025-11-13T12:50:35.000Z - 9 months ago

Vivani Medical reports Q3 EPS (11c) vs (11c) last year

Nov 13, 2025, 7:45 AM EST - 9 months ago

Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results

Oct 30, 2025, 1:30 PM EDT - 10 months ago

Vivani Medical Transcript: 2025 ThinkEquity Conference

2025-10-03T12:35:29.000Z - 11 months ago

Vivani Medical withdraws record date for spin-off of Cortigent

Oct 3, 2025, 8:30 AM EDT - 11 months ago

Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off

Sep 25, 2025, 1:45 PM EDT - 11 months ago

Vivani Medical Transcript: Emerging Growth Conference 2025

Sep 24, 2025, 9:15 AM EDT - 11 months ago

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025

2025-09-17T12:40:31.000Z - 1 year ago

Vivani Medical announces spin-off of Cortigent subsidiary

Sep 17, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders

2025-09-04T12:35:19.000Z - 1 year ago

Vivani Medical provides update on plans for NPM-139 semaglutide implant

Sep 4, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management

Aug 20, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025

Aug 13, 2025, 4:20 PM EDT - 1 year ago

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 12:00 AM EDT - 1 year ago

Vivani Medical Quarterly report: Q2 2025

Aug 13, 2025, 12:00 AM EDT - 1 year ago

Vivani Medical Earnings release: Q2 2025

2025-08-05T12:21:25.000Z - 1 year ago

Vivani Medical reports results from LIBERATE-1 study of NPM-115

2025-06-11T12:11:01.000Z - 1 year ago

Vivani Medical appoints Baldor as Chief Financial Officer

2025-05-29T12:40:35.000Z - 1 year ago

Vivani Medical files Form 10 registration statement for Cortigent spin-off

May 13, 2025, 4:30 PM EDT - 1 year ago

Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results

May 13, 2025, 12:00 AM EDT - 1 year ago

Vivani Medical Quarterly report: Q1 2025

May 13, 2025, 12:00 AM EDT - 1 year ago

Vivani Medical Earnings release: Q1 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical to Present at the American Association of Pharmaceutical Scientists' “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop

May 6, 2025, 8:00 AM EDT - 1 year ago

Vivani Medical Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Vivani Medical Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Vivani Medical Proxy statement: Proxy Filing

2025-04-15T12:40:34.000Z - 1 year ago

Vivani Medical, Okava expand collaboration to develop OKV-119 for dogs

Apr 15, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical Annual report: Q4 2024

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical Earnings release: Q4 2024

2025-03-31T11:42:16.000Z - 1 year ago

Vivani Medical announces anticipated upcoming milestones

Mar 31, 2025, 7:30 AM EDT - 1 year ago

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 27, 2025, 2:20 PM EDT - 1 year ago

Vivani Medical Transcript: Emerging Growth Virtual Conference

Mar 27, 2025, 7:32 AM EDT - 1 year ago

Vivani Medical Announces $8.25M Private Placement Equity Financing

Mar 26, 2025, 7:30 AM EDT - 1 year ago

Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing

Mar 24, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025

Mar 13, 2025, 7:30 AM EDT - 1 year ago

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults

Mar 12, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business

Jan 16, 2025, 3:10 PM EST - 1 year ago

Vivani Medical Transcript: Emerging Growth Virtual Conference 78

Dec 19, 2024, 8:30 AM EST - 1 year ago

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Dec 4, 2024, 8:30 AM EST - 1 year ago

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast

Nov 13, 2024, 8:30 AM EST - 1 year ago

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

Nov 13, 2024, 8:30 AM EST - 1 year ago

Vivani Medical Quarterly report: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Vivani Medical Slides: Q3 2024

Oct 22, 2024, 8:30 AM EDT - 1 year ago

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

Oct 17, 2024, 4:00 PM EDT - 1 year ago

Vivani Medical Transcript: Maxim Group’s 2024 Healthcare Virtual Summit

Sep 26, 2024, 8:30 AM EDT - 2 years ago

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Sep 23, 2024, 8:57 AM EDT - 2 years ago

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

Sep 11, 2024, 10:00 AM EDT - 2 years ago

Vivani Medical Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 4, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

Aug 28, 2024, 7:10 PM EDT - 2 years ago

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 14, 2024, 4:00 PM EDT - 2 years ago

Vivani Medical Quarterly report: Q2 2024

Aug 14, 2024, 4:00 PM EDT - 2 years ago

Vivani Medical Earnings release: Q2 2024

Aug 14, 2024, 4:00 PM EDT - 2 years ago

Vivani Medical Slides: Q2 2024

Aug 13, 2024, 4:05 PM EDT - 2 years ago

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

Jul 11, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

Jun 13, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

May 28, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

May 13, 2024, 4:45 PM EDT - 2 years ago

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

May 13, 2024, 4:45 PM EDT - 2 years ago

Vivani Medical Quarterly report: Q1 2024

May 13, 2024, 4:45 PM EDT - 2 years ago

Vivani Medical Earnings release: Q1 2024

May 13, 2024, 7:00 AM EDT - 2 years ago

Vivani Medical Slides: Investor Presentation

May 9, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical to Present at TIDES Conference 2024

May 2, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Registration statement: Registration Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Proxy statement: Proxy Filing

Apr 22, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Registration statement: Registration Filing

Mar 26, 2024, 9:30 AM EDT - 2 years ago

Vivani Medical Earnings release: Q4 2023

Mar 26, 2024, 9:30 AM EDT - 2 years ago

Vivani Medical Annual report: Q4 2023

Mar 26, 2024, 8:30 AM EDT - 2 years ago

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 6, 2024, 8:00 AM EST - 2 years ago

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Mar 1, 2024, 7:49 AM EST - 2 years ago

Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

Feb 29, 2024, 7:25 AM EST - 2 years ago

Vivani Medical (VANI) stock price surged: is it a good buy?

Feb 28, 2024, 8:30 AM EST - 2 years ago

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

BiotechSheff Aug. 19 at 2:33 PM

$VANI … $1.50 I think Novo-Nordisk thinks they nail this study in Nov when data released that’s why the partnership!

0 · Reply

TradeMark79 Aug. 19 at 2:10 PM

$VANI added this morning…GLTA!

0 · Reply

Kkai14 Aug. 19 at 11:08 AM

$VANI needs a move like CLRO 🤞

0 · Reply

shahidattar Aug. 19 at 2:03 AM

$VANI seems like it's going cuckooo

0 · Reply

TradeMark79 Aug. 18 at 8:13 PM

$VANI watching 🤙🏼

0 · Reply

GreeneggsandJam Aug. 18 at 8:06 PM

$VANI I established a position end of march. Finally some movement

0 · Reply

martyn78 Aug. 15 at 2:05 PM

$VANI this one keeps giving me reasons to look again

0 · Reply

focafoca99 Aug. 13 at 8:55 PM

$VANI emphasized its Q2 2026 financial results and business update in a press release attached to the 8-K. https://www.rapidticker.com/news/vani-sec-filing-ba1c76

0 · Reply

Kkai14 Aug. 12 at 9:41 AM

$VANI waiting......🤞

1 · Reply

ebk81 Aug. 11 at 8:19 AM

0 · Reply

wolfcyd3 Aug. 10 at 12:12 PM

$VANI upcoming catalysts and strong chart forming

0 · Reply

66Harry Aug. 9 at 1:31 PM

$VANI strong growth

0 · Reply

Daque Aug. 8 at 6:34 PM

$VANI MACD line just crossed signal line...

1 · Reply

Ele82 Aug. 8 at 10:40 AM

$VANI

0 · Reply

Kkai14 Aug. 7 at 9:56 AM

$CLRO $VANI NEXT.....

0 · Reply

Kkai14 Aug. 7 at 6:26 AM

$CLRO $VANI

0 · Reply

Vivani_Medical Aug. 6 at 6:41 PM

Today, Vivani Medical announced full enrollment and successful initial dosing of all 20 participants in the SLIM-1™ Phase 1 trial of NPM-139. https://investors.vivani.com/investors/news-events/press-releases/detail/222/vivani-medical-announces-successful-dosing-of-all $VANI

0 · Reply

Vivani_Medical Aug. 6 at 6:39 PM

$VANI Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

0 · Reply

MarketPulsee Aug. 6 at 5:55 PM

TRADE ALERT 🚨 $100K worth of trades executed today across 5 different stocks. Can you guess which ones? Hint: Not: $IONQ $WEN $PYPL $VANI $NVDA The market is always creating new opportunities. The question is: Which names are seeing the strongest conviction and capital flow right now? Drop your guesses below 👇 Follow my profile for more trade ideas, market setups, and real-time investing insights.

0 · Reply

Kkai14 Aug. 6 at 2:34 PM

$VANI why is this not flying 🥴

0 · Reply

Kkai14 Aug. 6 at 12:57 PM

$VANI

0 · Reply

ballyhooo Aug. 6 at 12:37 PM

$VANI nice $70M market cap boost on this $CLRO move!

1 · Reply

Market Cap	116.42M
Revenue (ttm)	0.00
Net Income (ttm)	-26.61M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	349,700
Avg Vol	523,320
Day's Range	N/A - N/A
Shares Out	86.24M
Stochastic %K	100%
Beta	2.35
Analysts	Strong Sell
Price Target	$3.83